Dr. Norman W. Baylor is an expert in the development and licensure of new vaccines, evaluating numerous vaccines throughout his career including vaccines for acellular pertussis, varicella, pneumococcal conjugate, human papillomavirus (HPV), influenza and shingles. He is currently the president and CEO of Biologics Consulting Group, Inc, where he is responsible for the overall management and strategic direction of the company.
Prior to this, he spent 20 years at the U.S. Food and Drug Administration (FDA), most recently as Director of the Office of Vaccines Research and Review (OVRR) in the Center for Biologics Evaluation and Research (CBER). In this role, he oversaw all facets of the clinical and product regulatory review activity, including quality assurance and oversight of review functions in addition to planning, developing and administering CBER’s broad national and international programs and operational activities for vaccines and related products. Dr. Baylor served as FDA’s liaison to CDC’s Advisory Committee on Immunization Practices, the U.S. Department of Health and Human Services National Vaccine Advisory Committee, and the Advisory Commission on Childhood Vaccines. He served on the board of the Infectious Disease Research Institute and continues to serve as an expert advisor to the World Health Organization on several global vaccine initiatives.
Dr. Baylor received his bachelor’s degree in medical microbiology from the University of Wisconsin, Madison, and his master’s degree and doctorate in microbial genetics and molecular microbiology, respectively, from the University of Kentucky.
We make vaccines more accessible, enable innovation and expand immunization across the globe.